MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Cytocom, Inc.
Attachments
Cytocom, Inc. – novel immunotherapies targeting autoimmune diseases, infectious diseases, inflammatory diseases, and cancers
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
*Architects: Crohn's Disease
Architects: Multiple Sclerosis (MS)
Companies: Merger Partners_(M&A)
Children
2021: Cleveland BioLabs, Inc. Files Registration Statement for Proposed Merger with Cytocom Inc.
Cleveland BioLabs, Inc. (CBLI)
Cytocom has four programs in late-stage clinical development in Crohn's disease, Fibromyalgia, Multiple Sclerosis and Pancreatic Cancer.
Cytocom Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis.
Fort Collins, Colorado
Founded 2013